First safety test for new drug in people with kidney disease
NCT ID NCT06845813
Summary
This early-stage study tested how a single dose of an experimental drug, AZD6234, is processed by the body in people with different levels of kidney problems. Researchers compared 24 people with mild to severe kidney impairment, including some on dialysis, to healthy volunteers. The main goal was to see if the drug is safe and how it behaves in people with reduced kidney function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Lake Forest, California, 92630, United States
-
Research Site
Orlando, Florida, 32808, United States
-
Research Site
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.